16-30 of 825
Improving Migraine Diagnosis in Vulnerable Populations
NeuroFrontiersImproving Migraine Diagnosis in Vulnerable Populations
Juliana VanderPluym, MD
The Role of CGRPs in First-Line Preventive Migraine Therapy
NeuroFrontiersThe Role of CGRPs in First-Line Preventive Migraine Therapy
Charles Turck, PharmD, BCPS, BCCCP
Richard B. Lipton, MD
Hope O'Brien, MD, MBA, FAHS, FAAN
Navigating Stem Cell Therapy Conversations in MS
NeuroFrontiersNavigating Stem Cell Therapy Conversations in MS
Jaime Imitola, MD
Spotting the Warning Signs of Subarachnoid Hemorrhage
NeuroFrontiersSpotting the Warning Signs of Subarachnoid Hemorrhage
Jay Max Findlay
The Critical Next Steps After Subarachnoid Hemorrhage Diagnosis
NeuroFrontiersThe Critical Next Steps After Subarachnoid Hemorrhage Diagnosis
Jay Max Findlay
The Recovery Trajectory of Subarachnoid Hemorrhage
NeuroFrontiersThe Recovery Trajectory of Subarachnoid Hemorrhage
Jay Max Findlay
- advertisement
Evaluating Delayed Presentations of Subarachnoid Hemorrhage
NeuroFrontiersEvaluating Delayed Presentations of Subarachnoid Hemorrhage
Jay Max Findlay
Cognitive Screening in MS: Practical Strategies and Modern Approaches
NeuroFrontiersCognitive Screening in MS: Practical Strategies and Modern Approaches
Elizabeth S. Gromisch, PhD
Advancing Cognitive Screening and Monitoring in MS
NeuroFrontiersAdvancing Cognitive Screening and Monitoring in MS
Elizabeth S. Gromisch, PhD
Consensus-Driven Outcomes for Aneurysmal Subarachnoid Hemorrhage Research
NeuroFrontiersConsensus-Driven Outcomes for Aneurysmal Subarachnoid Hemorrhage Research
Mobilization Outcomes After Aneurysmal Subarachnoid Hemorrhage
NeuroFrontiersMobilization Outcomes After Aneurysmal Subarachnoid Hemorrhage
How Real-World Adherence Is Shaping Preventive Migraine Treatment
NeuroFrontiersHow Real-World Adherence Is Shaping Preventive Migraine Treatment
Alexandria May, PharmD, BCPS
Jessica Ailani, MD, FAHS, FAAN, FANA
- advertisement
Recognizing TK2d: Key Clinical Signs and Diagnostic Protocols
NeuroFrontiersRecognizing TK2d: Key Clinical Signs and Diagnostic Protocols
Alexandria May, PharmD, BCPS
Kaitlin Batley, MD
Identifying the Respiratory Manifestations of TK2d: The Pulmonologist’s Role
NeuroFrontiersIdentifying the Respiratory Manifestations of TK2d: The Pulmonologist’s Role
Charles Turck, PharmD, BCPS, BCCCP
Bethany Lussier, MD
Understanding Variability in Myasthenia Gravis
NeuroFrontiersUnderstanding Variability in Myasthenia Gravis
Henry Kaminski, MD
